Traumatic brain injury (TBI) is a global cause of morbidity and mortality. Initial management and risk stratification of patients with TBI is made difficult by the relative insensitivity of screening radiographic studies as well as by the absence of a ...
Read More »Researchers using exosome IV to treat traumatic brain injury
A team of researchers from the University of Georgia’s Regenerative Bioscience Center has found that neural exosomes—“cargo” molecules within the nervous system that carry messages to the brain...
Read More »NeurExo Sciences to Host Teach-in Featuring Pioneering Exosome Technology
NeurExo Sciences, LLC (NXS), a biopharmaceutical company and subsidiary of NeuroTrauma Sciences, LLC, will be hosting a teach-in event featuring leading exosome researcher, Michael Chopp, Ph.D., Vice Chairman, Department of Neurology and Scientific Director, Neurosciences Institute, Zoltan J. Kovacs Chair of ...
Read More »Emerging potential of exosomes for treatment of traumatic brain injury
Traumatic brain injury (TBI) is one of the major causes of death and disability worldwide. No effective treatment has been identified from clinical trials. Compelling evidence exists that treatment with mesenchymal stem cells (MSCs) exerts a substantial therapeutic effect after ...
Read More »Systemic administration of cell-free exosomes improves functional recovery after traumatic brain injury
Multipotent human bone marrow derived mesenchymal stem cells (hMSCs) improve functional outcome after experimental traumatic brain injury (TBI). The present study was designed to investigate whether systemic administration of cell-free exosomes generated from hMSCs cultured in 2-dimensional (2D) conventional conditions ...
Read More »Exosomes may hold the key to diagnosing brain injuries in NFL players
from Neurology Advisor by Alicia Ciccone Researchers may have uncovered a way to detect chronic traumatic encephalopathy (CTE) in living individuals with a blood test that detects plasma exosomal tau. The preliminary results were published in the Journal of Alzheimer’s ...
Read More »Aethlon Medical and Exosome Sciences Announce Brain Research Discoveries
Discoveries Could Have Implications in the Diagnosis, Monitoring and Treatment of Alzheimer’s Disease, Chronic Traumatic Encephalopathy and Traumatic Brain Injury SAN DIEGO, March 5, 2014 /PRNewswire/ — Aethlon Medical, Inc. (otcqx:AEMD), and its diagnostic subsidiary, Exosome Sciences, Inc. (ESI), announced today ...
Read More »